| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | immunogenicity | View |
| None | safety | View |
| None | tetanus | View |
| None | diphtheria | View |
| None | acellular | View |
| None | pertussis | View |
| None | vaccine | View |
| None | booster | View |
| None | adverse event | View |
| None | adverse reaction | View |
| None | DT1aP | View |
| None | DT5ap | View |
| None | FHA | View |
| None | fimbriae | View |
| None | pertactin | View |
| None | SMI | View |
| None | Smittskyddsinstitutet | View |
| None | Immune response and safety profile to a Tdap booster | View |